By using this website you agree that we use cookies. You can find out more in the privacy policy.
Bombay Durpun - Nobel prize goes to mRNA Covid vaccine researchers
-
-
Choose a language
Automatically close in : 3
Wie gewohnt mit Werbung lesen
Nutzen Sie Bombay Durpun mit personalisierter Werbung, Werbetracking, Nutzungsanalyse und externen Multimedia-Inhalten. Details zu Cookies und Verarbeitungszwecken sowie zu Ihrer jederzeitigen Widerrufsmöglichkeit finden Sie unten, im Cookie-Manager sowie in unserer Datenschutzerklärung.
Use Bombay Durpun with personalised advertising, ad tracking, usage analysis and external multimedia content. Details on cookies and processing purposes as well as your revocation option at any time can be found below, in the cookie manager as well as in our privacy policy.
Utilizar Bombay Durpun con publicidad personalizada, seguimiento de anuncios, análisis de uso y contenido multimedia externo. Los detalles sobre las cookies y los propósitos de procesamiento, así como su opción de revocación en cualquier momento, se pueden encontrar a continuación, en el gestor de cookies, así como en nuestra política de privacidad.
Utilisez le Bombay Durpun avec des publicités personnalisées, un suivi publicitaire, une analyse de l'utilisation et des contenus multimédias externes. Vous trouverez des détails sur les cookies et les objectifs de traitement ainsi que sur votre possibilité de révocation à tout moment ci-dessous, dans le gestionnaire de cookies ainsi que dans notre déclaration de protection des données.
Utilizzare Bombay Durpun con pubblicità personalizzata, tracciamento degli annunci, analisi dell'utilizzo e contenuti multimediali esterni. I dettagli sui cookie e sulle finalità di elaborazione, nonché la possibilità di revocarli in qualsiasi momento, sono riportati di seguito nel Cookie Manager e nella nostra Informativa sulla privacy.
Utilizar o Bombay Durpun com publicidade personalizada, rastreio de anúncios, análise de utilização e conteúdo multimédia externo. Detalhes sobre cookies e fins de processamento, bem como a sua opção de revogação em qualquer altura, podem ser encontrados abaixo, no Gestor de Cookies, bem como na nossa Política de Privacidade.
Katalin Kariko and Drew Weissman won the Nobel Medicine Prize on Monday for work on messenger RNA (mRNA) technology that paved the way for groundbreaking Covid-19 vaccines.
Text size:
The pair, who had been tipped as favourites, "contributed to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times," the jury said.
The mRNA vaccines were approved for use in December 2020, and together with other Covid vaccines "have saved millions of lives and prevented severe disease in many more," the jury said.
Kariko, 68, and Weissman, 64, longstanding colleagues at the University of Pennsylvania in the US, have won a slew of awards for their research, including the prestigious Lasker Award in 2021, often seen as a precursor to the Nobel.
In honouring the duo this year, the Nobel committee in Stockholm broke with its usual practice of honouring decades-old research to ensure it stands the test of time.
While the prizewinning research dates back to 2005, the first vaccines to use the mRNA technology were those made by Pfizer/BioNTech and Moderna against Covid-19.
Unlike traditional vaccines which use weakened virus or a key piece of the virus' protein, mRNA vaccines provide the genetic molecules that tell cells what proteins to make, which simulates an infection and trains the immune system for when it encounters the real virus.
The honour is surely sweet for Kariko, who toiled in obscurity for years and struggled to convince her superiors of the need for research on "messenger ribonucleic acid".
Speaking to Swedish Radio, she said her late mother used to listen to the Nobel prize announcements in the hopes of hearing her daughter's name.
"She listened year after year. Unfortunately five years ago she passed at the age of 89. She might be listening from above."
In the 1990s, Kariko believed mRNA held the key to treating diseases where having more of the right kind of protein can help -- like repairing the brain after a stroke.
But the University of Pennsylvania, where Kariko was on track for a professorship, decided to pull the plug after the grant rejections piled up.
- Sweet comeback -
Much of the scientific community was at the time focused on using DNA to deliver gene therapy, but Kariko believed that mRNA was also promising since most diseases are not hereditary and don't need solutions that permanently alter our genetics.
First though, she had to overcome the problem of the massive inflammatory response in animal experiments, as the immune system sensed an invader and rushed to fight it.
Kariko and Weissman discovered that one of the four building blocks of the synthetic mRNA was at fault -- and they could overcome the problem by swapping it out with a modified version.
They published a paper on the breakthrough in 2005.
Then, in 2015, they found a new way to deliver mRNA into mice, using a fatty coating called "lipid nanoparticles" that prevent the mRNA from degrading, and help place it inside the right part of cells.
Both these innovations were key to the Covid-19 vaccines developed by Pfizer/BioNTech and Moderna.
Their mRNA technology is now being used to develop other treatments for diseases and illnesses such as cancer, influenza and heart failure.
The pair will receive their Nobel prize, consisting of a diploma, a gold medal and a $1 million cheque, from King Carl XVI Gustaf at a formal ceremony in Stockholm on December 10, the anniversary of the 1896 death of scientist Alfred Nobel who created the prizes in his last will and testament.
The Nobel will however not be the first gold medal in Kariko's family -- her daughter Susan Francia is a two-time time Olympic gold medalist rower.